- Home
- PMVP vs TTOO Comparison
PMVP vs TTOO Comparison
Compare PMVP & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- TTOO
- Stock Information
- Founded
- PMVP 2013
- TTOO 2006
- Country
- PMVP United States
- TTOO United States
- Employees
- PMVP N/A
- TTOO N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- TTOO Medical/Dental Instruments
- Sector
- PMVP Health Care
- TTOO Health Care
- Exchange
- PMVP Nasdaq
- TTOO Nasdaq
- Market Cap
- PMVP 85.5M
- TTOO 36.4M
- IPO Year
- PMVP 2020
- TTOO 2014
- Fundamental
- Price
- PMVP $1.65
- TTOO $0.97
- Analyst Decision
- PMVP Strong Buy
- TTOO Hold
- Analyst Count
- PMVP 4
- TTOO 1
- Target Price
- PMVP $5.75
- TTOO $5.00
- AVG Volume (30 Days)
- PMVP 185.0K
- TTOO 710.5K
- Earning Date
- PMVP 11-07-2024
- TTOO 11-13-2024
- Dividend Yield
- PMVP N/A
- TTOO N/A
- EPS Growth
- PMVP N/A
- TTOO N/A
- EPS
- PMVP N/A
- TTOO N/A
- Revenue
- PMVP N/A
- TTOO $7,164,000.00
- Revenue This Year
- PMVP N/A
- TTOO $50.31
- Revenue Next Year
- PMVP N/A
- TTOO $117.92
- P/E Ratio
- PMVP N/A
- TTOO N/A
- Revenue Growth
- PMVP N/A
- TTOO N/A
- 52 Week Low
- PMVP $1.33
- TTOO $0.90
- 52 Week High
- PMVP $3.47
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- PMVP 60.86
- TTOO 18.34
- Support Level
- PMVP $1.63
- TTOO $0.90
- Resistance Level
- PMVP $1.69
- TTOO $1.86
- Average True Range (ATR)
- PMVP 0.07
- TTOO 0.15
- MACD
- PMVP 0.01
- TTOO -0.00
- Stochastic Oscillator
- PMVP 52.65
- TTOO 5.72
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.